VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: 777 Captain who wrote (19876)	3/19/1999 8:36:00 AM
From: BigKNY3	Read Replies (2) of 23519

777 Captain <<The biggest "fly in the ointment" at present is lack of a US sales force.>> 777: The real "fly" is the state of MUSE Rx specification in the US(and resulting revenues). Unfortunately, this key trend data is no longer shared on any of the VVUSer Boards. Accordingly, you can assume the 1999 trend is not very favorable...As you noted, it is virtually impossible to generate Rx specification without field representatives...It will be a very positive sign when this Rx data once again becomes posted on a weekly basis and indicates growth. For those interested VVUSers, weekly Rx data of major new products are posted by Merrill Lynch at their complimentary Research Website. Their research reports are also some of the best in the industry. You will need to register and then type in the ticker name of any Big Pharma. askmerrill.com BigKNY3

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next